"Klinika Dermatologii i Medycyny Estetycznej z Ośrodkiem Badań Klinicznych."

During the past decade, Royalderm Agnieszka Nawrocka conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royalderm Agnieszka Nawrocka" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Concert Pharmaceuticals" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "Royalderm Agnieszka Nawrocka" are "Alopecia Areata" (4 trials), "Psoriasis" (4 trials), "Plaque Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials) and "Skin Diseases" (2 trials). Many other conditions were trialed in "Royalderm Agnieszka Nawrocka" in a lesser frequency.

Most popular intervention types in "Royalderm Agnieszka Nawrocka" are "Drug" (15 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Adalimumab" (2 trials), "BMS-986165" (2 trials), "Bermekimab" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royalderm Agnieszka Nawrocka" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Royalderm Agnieszka Nawrocka". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Royalderm Agnieszka Nawrocka, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Royalderm Agnieszka Nawrocka, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".